In conclusion, our study demonstrated that as a trigger indicator in IPF, the senescence process in AECs should be a potential therapeutic target and that the PTEN/Akt pathway may be a promising candidate for intervention. This evidence concerns the gene AKT1 and idiopathic pulmonary fibrosis.